Molecularly targeted therapy and radiotherapy in the management of localized gastrointestinal stromal tumor (GIST) of the rectum: A case report

Marzia Ciresa, Rolando Maria D'Angelillo, Sara Ramella, Francesco Cellini, Diego Gaudino, Gerardina Stimato, Michele Fiore, Carlo Greco, Raffaele Nudo, Lucio Trodella

Risultato della ricerca: Contributo in rivistaArticolo in rivista

Abstract

Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal neoplasms of the gastrointestinal tract. The main treatment for localized gastrointestinal stromal tumors is surgical resection. These tumors respond poorly to conventional cytotoxic chemotherapy agents and to radiotherapy. Imatinib mesylate, a small-molecule kinase inhibitor, has proved useful in the treatment of recurrent or metastatic GISTs and is now being tested in the adjuvant and neoadjuvant setting. The role of radiotherapy in the management of patients with GIST is currently restricted to symptomatic palliation. We present the case of a 54-year-old man affected by rectal GIST extending to the anal canal, with constipation, hematochezia, and anal pain. He received imatinib, 400 mg orally per day, for a week before and during radiation therapy. Irradiation was delivered to the gross tumor volume by 3D conformal therapy. The planned total dose was 50.4 Gy in fractions of 1.8 Gy daily. We observed a partial clinical response 3 weeks after the end of combination treatment. The patient then underwent a sphincter-saving surgical procedure. There was no perioperative morbidity and a complete pathological response was obtained. At the present time, the role of radiotherapy in the management of patients with GIST is restricted to symptomatic palliation. The introduction of molecularly targeted therapy combined with radiation therapy could improve the outcomes for patients diagnosed with GIST.
Lingua originaleEnglish
pagine (da-a)236-239
Numero di pagine4
RivistaTumori
Volume95
DOI
Stato di pubblicazionePubblicato - 2009

Keywords

  • Imatinib
  • Localized gastrointestinal stromal tumor
  • Neoadjuvant radiotherapy

Fingerprint

Entra nei temi di ricerca di 'Molecularly targeted therapy and radiotherapy in the management of localized gastrointestinal stromal tumor (GIST) of the rectum: A case report'. Insieme formano una fingerprint unica.

Cita questo